시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 좌골 신경통 시장 보고서(2024년)
Sciatica Global Market Report 2024
상품코드 : 1415747
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 7,234,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,851,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 14,469,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

좌골 신경통 시장 규모는 최근 몇 년동안 강력한 성장세를 보이며 2023년 65억 2,000만 달러에서 2024년에는 69억 3,000만 달러에 달하고, CAGR 6.3%로 확대될 것으로 예상됩니다. 실적 기간의 성장은 혁신적인 통증 관리 솔루션, 디지털 헬스, 원격 의료, 맞춤 치료 접근법, 통합 치료 모델에 기인합니다.

정형외과적 시술의 급증은 향후 몇 년동안 좌골신경통 시장의 성장을 견인할 것으로 보입니다. 이러한 시술에는 척추 및 관절 상태를 해결하고 골격의 불균형을 교정하는 것을 목표로 하는 개입이 포함됩니다. 좌골신경통의 치료는 통증을 완화하고 이동성과 기능을 회복하며 궁극적으로 이 증상으로 고통받는 환자의 삶의 질을 향상시키는 데 매우 중요합니다. 예를 들어, 2023년 2월 미국 국립의학도서관(National Library of Medicine)이 발표한 연구에 따르면, 2040년까지 고관절 전치환술(THA)과 슬관절 전치환술(TKA)이 크게 증가하여 각각 719,364명, 1,222,988명씩 증가할 것으로 예상됩니다. 또한 2060년까지 TKA는 2,917,959건, THA는 1,982,099건에 달할 것으로 예측됩니다. 이러한 정형외과 수술의 급증은 2040년 좌골신경통 시장 성장의 원동력이 되고 있습니다. 또한 TKA는 2060년까지 2,917,959건, THA는 1,982,099건에 달할 것으로 예측됩니다. 따라서 정형외과 수술 건수 증가가 좌골신경통 시장의 성장을 주도하고 있습니다.

2023년 좌골 신경통 시장에서 가장 규모가 큰 지역은 북미입니다. 아시아태평양은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 좌골신경통 보고서의 대상 지역은 아시아태평양, 서유럽, 중동 및 동유럽, 북미, 남미, 중동 및 아프리카입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 및 혁신적인 기업

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 가능성 분석

제36장 부록

LSH
영문 목차

영문목차

“Sciatica Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sciatica market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sciatica? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The sciatica market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

Executive Summary

Sciatica is characterized by pain resulting from inflammation, irritation, or compression of the sciatic nerve, typically occurring in the leg due to pressure or injury. Physical therapy proves effective in alleviating sciatica by enhancing flexibility, strength, and range of motion, thereby reducing pressure on the affected nerve.

There are several types of sciatica, including acute and chronic sciatica. Acute sciatica is characterized by lower back pain that can last for up to six weeks and is typically caused by pressure or injury to the sciatic nerve. Treatment options for sciatica encompass a variety of drugs such as oxycodone, tramadol, opioid analgesics, amitriptyline, tricyclic antidepressants, among others. Additionally, treatments may involve medication regimens and surgical interventions, catering to a diverse range of end-users including hospitals, homecare, specialty clinics, and other healthcare facilities.

The sciatica market research report is one of a series of new reports from The Business Research Company that provides sciatica market statistics, including sciatica industry global market size, regional shares, competitors with a sciatica market share, detailed sciatica market segments, market trends and opportunities and any further data you may need to thrive in the sciatica industry. This sciatica market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sciatica market size has grown strongly in recent years. It will grow from $6.52 billion in 2023 to $6.93 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to innovative pain management solutions, digital health, telemedicine, personalized treatment approaches, integrative care models.

The sciatica market size is expected to see strong growth in the next few years. It will grow to $8.59 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include advanced diagnostic imaging, regenerative medicine, digital therapeutics, preventive measures.

The surge in orthopedic procedures is poised to drive the growth of the sciatica market in the coming years. These procedures encompass interventions aimed at addressing conditions in the spine, joints, and rectifying skeletal irregularities. Treatment for sciatica is pivotal in delivering enhanced pain relief, reinstating mobility and function, ultimately leading to an improved quality of life for patients grappling with this condition. The involvement of orthopedic doctors and surgeons is often instrumental in both diagnosing and treating sciatica.For instance, in February 2023, research published by the National Library of Medicine indicated a substantial rise in total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures, with projections of 719,364 and 1,222,988 increase, respectively, by the year 2040. Moreover, TKAs are expected to reach 2,917,959 by 2060, while THAs are projected to total 1,982,099 by that time. This surge in orthopedic procedures serves as a driving force for the growth of the sciatica market. year 2040. Moreover, TKAs are expected to reach 2,917,959 by 2060, while THAs are projected to total 1,982,099 by that time. Therefore, the increasing number of orthopedic procedures is driving the growth of the sciatica market.

The increasing prevalence of back problems is expected to be a significant driver for the growth of the sciatica market in the foreseeable future. Back problems encompass a range of mechanical or structural issues that manifest in the spine, discs, muscles, ligaments, tendons, or involve the compression of nerves in the back. This surge in back problems can subsequently lead to an uptick in the sciatica market, as individuals experiencing back issues are more prone to developing sciatica. Consequently, there is a heightened demand for products and services aimed at alleviating sciatica-related pain. For instance, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that back pain and related issues accounted for 4.2% of the country's total disease burden in 2021. This positioned back problems as the third most prevalent cause of disease burden. Notably, back problems were identified as the primary diagnosis in 192,000 hospital admissions, equating to a rate of 750 admissions per 100,000 individuals. This underscores how the increasing prevalence of back problems is a significant driving force behind the growth of the sciatica market.

The growth of the sciatica market is anticipated to be impeded by the high expenses associated with treatment. The substantial cost of sciatica treatment poses a significant challenge for patients in need of such care. Moreover, these elevated costs might dissuade companies from committing resources to research and development efforts for new sciatica treatments. For instance, in January 2021, according to The Lancet, a UK-based peer-reviewed journal, revealed that the average expenditure for treating low back pain, a category encompassing cases of sciatica, in emergency room and inpatient ward settings in Sydney, Australia, amounted to approximately $1,800 per patient. This underscores the considerable financial burden associated with sciatica treatment. Consequently, the high costs linked to treatment serve as a notable constraint on the growth of the sciatica market.

Prominent companies in the sciatica market are actively engaged in the development and approval of innovative products in collaboration with federal agencies, as a strategic move to maintain their market standing. These advancements in sciatica therapy not only offer improved treatment options but also serve to mitigate side effects, enhance overall efficacy, and broaden the spectrum of available treatments. For instance, in June 2022, SciatiEase Labs, a US-based health supplement company, achieved approval for its product "SciatiEase" from the United States Food and Drug Administration (FDA), a federal agency in the United States. SciatiEase is a powerful supplement that amalgamates various beneficial elements into a single pill, designed to alleviate sporadic discomfort associated with sciatic nerve pain. These supplements are specifically crafted for individuals who regularly grapple with discomfort along the sciatic nerve and may face dietary restrictions that hinder their ability to naturally alleviate such discomfort.

In April 2023, Nura Pain Clinics, a US-based medical practice clinic, merged with Capitol Pain Institute Inc. for an undisclosed amount. This merger is poised to deliver an innovative and integrated approach to care, all while maintaining their shared commitment to aiding individuals enduring chronic pain. Capitol Pain Institute Inc., an American clinic specializing in interventional pain care, caters to a range of conditions, including sciatica and back pain.

Major players in the sciatica market are Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., Lupin Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the sciatica market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sciatica report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sciatica market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sciatica market consists of revenues earned by entities by providing services such as medication and heat therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The sciatica market also includes sales of muscle relaxants, which are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Sciatica Market Characteristics

3. Sciatica Market Trends And Strategies

4. Sciatica Market - Macro Economic Scenario

5. Global Sciatica Market Size and Growth

6. Sciatica Market Segmentation

7. Sciatica Market Regional And Country Analysis

8. Asia-Pacific Sciatica Market

9. China Sciatica Market

10. India Sciatica Market

11. Japan Sciatica Market

12. Australia Sciatica Market

13. Indonesia Sciatica Market

14. South Korea Sciatica Market

15. Western Europe Sciatica Market

16. UK Sciatica Market

17. Germany Sciatica Market

18. France Sciatica Market

19. Italy Sciatica Market

20. Spain Sciatica Market

21. Eastern Europe Sciatica Market

22. Russia Sciatica Market

23. North America Sciatica Market

24. USA Sciatica Market

25. Canada Sciatica Market

26. South America Sciatica Market

27. Brazil Sciatica Market

28. Middle East Sciatica Market

29. Africa Sciatica Market

30. Sciatica Market Competitive Landscape And Company Profiles

31. Sciatica Market Other Major And Innovative Companies

32. Global Sciatica Market Competitive Benchmarking

33. Global Sciatica Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sciatica Market

35. Sciatica Market Future Outlook and Potential Analysis

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기